CancerTools provides large, diverse collections of Patient–Derived Xenograft (PDX) models for breast cancer and lung cancer that are:
Highly valuable in recapitulating patient tumour characteristics, including intratumour heterogeneity, genomic features, metastatic patterns, and drug responses
Highly translatable preclinical models that can be used to more accurately test therapy efficacy and predict patient drug responses than traditional models
A superior choice for studying advanced cancers than traditional models that fail to accurately recapitulate metastasis
Access our PDX model collections for your research and preclinical drug discovery from leading cancer institutes.
Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.
